On the other hand, several studies including ours have demonstrated that hepatic FGF21 mRNA and serum FGF21 protein levels are increased in mice and humans with obesity and NAFLD38, 39, 40, suggesting that TG accumulation may trigger FGF21 expression in the liver. This evidence concerns the gene FGF21 and obesity disorder.